GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant. Sam Fazeli of Bloomberg Intelligence discusses the findings.
Glaxo Antibody Works Against Omicron Variant
